Payer denials have nearly doubled since 2020, and the organizations absorbing the damage are doing so quietly. For health system revenue cycle leaders, the question is no longer whether denials are a strategic threat but whether their organizations are responding…
The Latest
Rural healthcare is at an inflection point. Hospitals are closing or scaling back essential services. Labor and delivery units are disappearing. Rural operating rooms sit idle not due to a lack of patients, but to a shortage of clinicians. At…
For years, denials have been framed as an operational nuisance. A downstream problem handled by appeals teams that are armed with spreadsheets and overtime hours. But in 2026, that framing no longer holds. The scale, speed and sophistication of payer…
Nearly one-third of clinicians say they now speak up when witnessing potentially harmful behavior by colleagues — up from 10% in 2005 — highlighting both progress and persistent safety culture gaps, according to 2025 survey data published March 26 in…
Purdue Pharma has been sentenced and ordered to pay more than $5 billion in criminal penalties for its role in fueling the opioid epidemic. A federal court in Newark, N.J., ordered a criminal fine of $3.544 billion and an additional…
There is a moment from my training that has stayed with me for years, not because it was unusual, but because it revealed something fundamental about how systems fail. I was a medical student in Colombia, working in a public…
This episode recorded live at the Becker’s Spring 2026 Payer Issues Roundtable features Dirk Soenksen, Chief Executive Officer of Ceresti Health, discussing why dementia is a major yet underrecognized cost driver and how it reshapes population health strategy. He highlights…
This episode recorded live at the Becker’s Spring 2026 Payer Issues Roundtable features Dirk Soenksen, Chief Executive Officer of Ceresti Health, discussing why dementia is a major yet underrecognized cost driver and how it reshapes population health strategy. He highlights…
This episode recorded live at the Becker’s Spring 2026 Payer Issues Roundtable features Dirk Soenksen, Chief Executive Officer of Ceresti Health, discussing why dementia is a major yet underrecognized cost driver and how it reshapes population health strategy. He highlights…
Health systems are finding that the biggest challenge with GLP-1 medications isn’t starting patients on therapy — it’s keeping them on it. During a panel at Becker’s Spring Chief Pharmacy Officer Summit, pharmacy and physician leaders said adherence has emerged…